| Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP Y Yuan, YM Liao, CT Hsueh, HR Mirshahidi Journal of hematology & oncology 4, 1-14, 2011 | 149 | 2011 |
| Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade … MJ Wagner, M Othus, SP Patel, C Ryan, A Sangal, B Powers, GT Budd, ... Journal for immunotherapy of cancer 9 (8), e002990, 2021 | 125 | 2021 |
| Combination antiangiogenic therapy and radiation in head and neck cancers HW Hsu, NR Wall, CT Hsueh, S Kim, RL Ferris, CS Chen, S Mirshahidi Oral oncology 50 (1), 19-26, 2014 | 123 | 2014 |
| Deprivation of arginine by recombinant human arginase in prostate cancer cells EC Hsueh, SM Knebel, WH Lo, YC Leung, PNM Cheng, CT Hsueh Journal of hematology & oncology 5, 1-6, 2012 | 111 | 2012 |
| UCN-01 suppresses thymidylate synthase gene expression and enhances 5-fluorouracil-induced apoptosis in a sequence-dependent manner. CT Hsueh, D Kelsen, GK Schwartz Clinical cancer research: an official journal of the American Association …, 1998 | 109 | 1998 |
| Selective inhibition of cyclooxygenase-2 enhances mitomycin-C-induced apoptosis CT Hsueh, CF Chiu, DP Kelsen, GK Schwartz Cancer chemotherapy and pharmacology 45, 389-396, 2000 | 101 | 2000 |
| Targeted and novel therapy in advanced gastric cancer JH Selim, S Shaheen, WC Sheu, CT Hsueh Experimental Hematology & Oncology 8 (1), 25, 2019 | 86 | 2019 |
| Hemolysis and hyperhomocysteinemia caused by cobalamin deficiency: three case reports and review of the literature U Acharya, JT Gau, W Horvath, P Ventura, CT Hsueh, W Carlsen Journal of hematology & oncology 1, 1-5, 2008 | 83 | 2008 |
| Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature MA Bautista, WT Stevens, CS Chen, BR Curtis, RH Aster, CT Hsueh Journal of Hematology & Oncology 3, 1-8, 2010 | 77 | 2010 |
| Concomitant KRAS and BRAF mutations in colorectal cancer L Midthun, S Shaheen, J Deisch, M Senthil, J Tsai, CT Hsueh Journal of gastrointestinal oncology 10 (3), 577, 2019 | 53 | 2019 |
| Conservative management of nivolumab-induced pericardial effusion: a case report and review of literature S Shaheen, H Mirshahidi, G Nagaraj, CT Hsueh Experimental Hematology & Oncology 7, 1-5, 2018 | 49 | 2018 |
| Pathological complete response after neoadjuvant chemotherapy with trastuzumab-containing regimen in gastric cancer: a case report J Wang, GW Saukel, CA Garberoglio, W Srikureja, CT Hsueh Journal of hematology & oncology 3, 1-4, 2010 | 47 | 2010 |
| Recent advances in gastrointestinal oncology-updates and insights from the 2009 annual meeting of the American Society of Clinical Oncology M Javle, CT Hsueh Journal of Hematology & Oncology 3, 1-11, 2010 | 44 | 2010 |
| Updates in Gastrointestinal Oncology – insights from the 2008 44th annual meeting of the American Society of Clinical Oncology M Javle, CT Hsueh Journal of Hematology & Oncology 2, 1-13, 2009 | 42 | 2009 |
| The role of bile acids in cellular invasiveness of gastric cancer YC Wu, CF Chiu, CT Hsueh, CT Hsueh Cancer cell international 18, 1-8, 2018 | 40 | 2018 |
| Regulation of folate-binding protein gene expression by DNA methylation in methotrexate-resistant KB cells CT Hsueh, BJ Dolnick Biochemical pharmacology 47 (6), 1019-1027, 1994 | 37 | 1994 |
| Novel biomarkers for diagnosis, prognosis, targeted therapy and clinical trials CT Hsueh, D Liu, H Wang Biomarker research 1, 1-2, 2013 | 35 | 2013 |
| Gastric bleeding due to graft-vs-host disease: discrepancy between endoscopic and histologic assessment SP Yeh, YM Liao, CH Hsu, CL Chen, YC Shen, CT Hsueh, HH Huang, ... American journal of clinical pathology 122 (6), 919-925, 2004 | 33 | 2004 |
| Co-overexpression of cyclooxygenase-2 and microsomal prostaglandin E synthase-1 adversely affects the postoperative survival in non-small cell lung cancer YC Wu, LJ Su, HW Wang, CFJ Lin, WH Hsu, TY Chou, CYF Huang, CL Lu, ... Journal of Thoracic Oncology 5 (8), 1167-1174, 2010 | 32 | 2010 |
| UCN-01 suppresses E2F-1 mediated by ubiquitin-proteasome-dependent degradation CT Hsueh, YC Wu, GK Schwartz Clinical cancer research 7 (3), 669-674, 2001 | 28 | 2001 |
